23,178 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Worldquant Millennium Advisors LLC

Worldquant Millennium Advisors LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 23,178 shares of the biotechnology company's stock, valued at approximately $13,775,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Willis Johnson & Associates Inc. bought a new position in Axon Enterprise in the fourth quarter valued at $225,000. Woodline Partners LP bought a new position in Axon Enterprise in the fourth quarter valued at $2,929,000. Square Wave Partners L.P. bought a new position in Axon Enterprise in the fourth quarter valued at $17,220,000. Twinbeech Capital LP bought a new position in Axon Enterprise in the fourth quarter valued at $26,877,000. Finally, Two Sigma Advisers LP grew its position in Axon Enterprise by 230.2% in the fourth quarter. Two Sigma Advisers LP now owns 220,600 shares of the biotechnology company's stock valued at $131,107,000 after purchasing an additional 153,800 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

AXON has been the subject of a number of analyst reports. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Needham & Company LLC raised their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Barclays lifted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $652.73.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,969 shares of company stock valued at $23,127,314. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $7.62 during midday trading on Friday, hitting $731.37. 422,330 shares of the company were exchanged, compared to its average volume of 743,966. The firm has a market capitalization of $56.94 billion, a P/E ratio of 188.98, a PEG ratio of 5.17 and a beta of 1.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm's 50 day moving average price is $603.25 and its two-hundred day moving average price is $604.88. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $748.80.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the firm posted $1.15 EPS. Axon Enterprise's revenue was up 31.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.